top of page
  • Writer's pictureDakila News

CRISPR - The Nobel Prize-Winning Genetic Editing Technique of 2020

In the annals of scientific achievement, few discoveries have sparked as much excitement and debate as CRISPR, an acronym for "Clustered Regularly Interspaced Short Palindromic Repeats." This revolutionary breakthrough represents a genetic editing technique rooted in a DNA sequence found in select bacteria, integral to their defense system.


The unveiling of this groundbreaking technique came in 2012, gracing the pages of the esteemed scientific journal "Science." In a historic turn of events, the duo of scientists responsible for its revelation would be awarded the Nobel Prize in Chemistry in 2020. The Nobel committee hailed CRISPR as a tool with the potential to cure hereditary diseases, thus setting the stage for a new era in medical science.


At the heart of CRISPR's revolutionary power lies the Cas proteins, which possess the remarkable ability to precisely snip DNA at a designated location, provided they are armed with the appropriate RNA guide. In essence, CRISPR/Cas9 serves as a genetic scalpel, allowing for the alteration of specific portions of a cell's genetic code.


Beyond the multitude of possibilities this tool offers, its operational mechanics are surprisingly straightforward. The Cas9 enzyme is employed to cut and modify DNA sections associated with the desired repair. This protein takes its cues from a guide RNA (sgRNA), synthesized in the lab to match the specific DNA sequence to be modified.


Claes Gustafsson, the president of the Nobel Prize in Chemistry committee, declared, "There is immense power in this genetic tool, one that impacts all of us. It has not only revolutionized basic science but has also led to innovative crop yields and promises groundbreaking medical treatments".


Owing to its ease of use, CRISPR has found extensive application in fundamental research, particularly in deciphering the functions and interactions of diverse genes. Armed with this foundational knowledge, applied research gains a comprehensive understanding of the myriad possibilities and limitations that can be explored.


As noted by geneticist Mayana Zatz, leader of the USP Genome Project, "We can derive cell lines from patients with various genetic diseases in the lab, and from their blood, we can create muscle cells, neurons, lung cells, you name it. With this technology, we aim to correct genetic defects to restore the clinical condition, or we can create mutations to observe the outcomes".


However, amid the scientific advances that CRISPR affords, it also ushers in a slew of bioethical discussions. One of the foremost concerns is the precision of the editing process, as the tool can inadvertently introduce unintended alterations.


Indeed, in November 2018, a Chinese researcher made headlines by conducting genetic editing on human embryos using CRISPR in an attempt to create HIV-immune individuals. These modified embryos ultimately gave rise to twin girls.


As a consequence, the researcher was dismissed from his university position and sentenced to three years in prison. That same year, a scientist from MIT underscored the imperative of refraining from editing the human DNA, highlighting the unpredictable ramifications of such actions.


In the midst of promise and peril, CRISPR stands as a testament to human ingenuity and the ever-evolving ethical dilemmas that accompany scientific progress. The journey of this genetic marvel continues to captivate the world, offering both hope and caution on the path to rewriting the code of life.


References (in portuguese):

Comments


bottom of page